Cargando…

Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma

BACKGROUND: Identification of genetic factors causing predisposition to renal cell carcinoma has helped improve screening, early detection, and patient survival. METHODS: We report the characterization of a proband with renal and thyroid cancers and a family history of renal and other cancers by who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicolas, Emmanuelle, Demidova, Elena V., Iqbal, Waleed, Serebriiskii, Ilya G., Vlasenkova, Ramilia, Ghatalia, Pooja, Zhou, Yan, Rainey, Kim, Forman, Andrea F., Dunbrack, Roland L., Golemis, Erica A., Hall, Michael J., Daly, Mary B., Arora, Sanjeevani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418363/ https://www.ncbi.nlm.nih.gov/pubmed/30680959 http://dx.doi.org/10.1002/mgg3.556

Ejemplares similares

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing
por: Demidova, Elena V., et al.
Publicado: (2023)

Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing
por: Demidova, Elena V., et al.
Publicado: (2023)

POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies
por: Nicolas, Emmanuelle, et al.
Publicado: (2016)

Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer
por: Nicolas, Emmanuelle, et al.
Publicado: (2015)

Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer
por: Hartman, Tiffiney R., et al.
Publicado: (2020)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
por: Skripova, Vera, et al.
Publicado: (2022)

RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy
por: Iqbal, Waleed, et al.
Publicado: (2021)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
por: Serebriiskii, Ilya G., et al.
Publicado: (2019)

Numb Independently Antagonizes Sanpodo Membrane Targeting and Notch Signaling in Drosophila Sensory Organ Precursor Cells
por: Tong, Xin, et al.
Publicado: (2010)

Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases
por: Vlasenkova, Ramilia, et al.
Publicado: (2021)

A gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) system
por: Sudomoina, Marina, et al.
Publicado: (2004)

Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
por: Serebriiskii, Ilya G., et al.
Publicado: (2022)

Rapid calcium-dependent activation of Aurora-A kinase
por: Plotnikova, Olga V., et al.
Publicado: (2010)

Delineating the RAS Conformational Landscape
por: Parker, Mitchell I., et al.
Publicado: (2022)

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin
por: Gaponova, Anna V., et al.
Publicado: (2016)

Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma
por: Han, Seunghun, et al.
Publicado: (2023)

High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes
por: Anderson, Joshua C., et al.
Publicado: (2015)

Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015)

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer
por: Beck, Tim N., et al.
Publicado: (2019)

Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma
por: Ghosh, Arindam P., et al.
Publicado: (2017)

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer
por: Serebriiskii, Ilya G., et al.
Publicado: (2023)

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer
por: Korobeynikov, Vladislav, et al.
Publicado: (2019)

Role of perioperative immunotherapy in localized renal cell carcinoma
por: Kaur, Jasmeet, et al.
Publicado: (2023)

Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States
por: Navalkele, Pournima, et al.
Publicado: (2020)

Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets
por: Ghatalia, Pooja, et al.
Publicado: (2016)

Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization
por: Ramirez, Ursula D., et al.
Publicado: (2015)

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
por: Peri, Suraj, et al.
Publicado: (2017)

DUSP6 regulates drug sensitivity by modulating DNA damage response
por: Bagnyukova, T V, et al.
Publicado: (2013)

Aurora A kinase activity influences calcium signaling in kidney cells
por: Plotnikova, Olga V., et al.
Publicado: (2011)

Dcas Supports Cell Polarization and Cell-Cell Adhesion Complexes in Development
por: Tikhmyanova, Nadezhda, et al.
Publicado: (2010)

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
por: Zhang, Tian, et al.
Publicado: (2020)

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
por: Makhov, Petr, et al.
Publicado: (2021)

Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population
por: Zhang, Ning, et al.
Publicado: (2016)

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2020)

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease
por: Beck, Tim N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_544jh9ue4ni7rddf4vmqjofa4p